These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9610452)

  • 1. Dose uniformity of ophthalmic suspensions.
    Diestelhorst M; Kwon KA; Süverkrup R
    J Cataract Refract Surg; 1998 May; 24(5):672-7. PubMed ID: 9610452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dosage problems in suspension eyedrops].
    Kwon KA; Diestelhorst M; Süverkrüp R
    Klin Monbl Augenheilkd; 1996; 209(2-3):144-9. PubMed ID: 8992075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of new ophthalmic suspension prednisolone acetate 1%.
    Akram M; Shyum SB; Gauhar S
    Pak J Pharm Sci; 2010 Apr; 23(2):149-54. PubMed ID: 20363691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro microstructural analysis of commercial ophthalmic suspensions by HRT II Rostock Cornea Module].
    Imre L; Resch M; Megyesi M; Németh J
    Ophthalmologe; 2007 Aug; 104(8):697-700, 702-4. PubMed ID: 17593371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A relevant choice for corticoid eye drops: solution or suspension?].
    Nourry H; Viard C; Cambourieu C; Warnet JM
    J Fr Ophtalmol; 2011 Dec; 34(10):691-6. PubMed ID: 22001623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical 0.1% indomethacin solution versus topical 0.1% dexamethasone solution in the prevention of inflammation after cataract surgery. The Study Group.
    Missotten L; Richard C; Trinquand C
    Ophthalmologica; 2001; 215(1):43-50. PubMed ID: 11125269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.
    Kassem MA; Abdel Rahman AA; Ghorab MM; Ahmed MB; Khalil RM
    Int J Pharm; 2007 Aug; 340(1-2):126-33. PubMed ID: 17600645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient compliance with use of topical ophthalmic corticosteroid suspensions.
    Apt L; Henrick A; Silverman LM
    Am J Ophthalmol; 1979 Feb; 87(2):210-4. PubMed ID: 434075
    [No Abstract]   [Full Text] [Related]  

  • 9. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability.
    Nagai N; Ito Y; Okamoto N; Shimomura Y
    Toxicology; 2014 May; 319():53-62. PubMed ID: 24598350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ocular Drug Delivery System-based on Solid Nanoparticles].
    Nagai N
    Yakugaku Zasshi; 2021; 141(1):47-53. PubMed ID: 33390447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose uniformity of loteprednol etabonate ophthalmic gel (0.5%) compared with branded and generic prednisolone acetate ophthalmic suspension (1%).
    Marlowe ZT; Davio SR
    Clin Ophthalmol; 2014; 8():23-9. PubMed ID: 24357925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melt-Cast Noninvasive Ocular Inserts for Posterior Segment Drug Delivery.
    Balguri SP; Adelli GR; Tatke A; Janga KY; Bhagav P; Majumdar S
    J Pharm Sci; 2017 Dec; 106(12):3515-3523. PubMed ID: 28778424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation of indomethacin eye drops via complexation with cyclodextrins.
    Halim Mohamed MA; Mahmoud AA
    Curr Eye Res; 2011 Mar; 36(3):208-16. PubMed ID: 21275515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of prednisolone acetate suspensions.
    Roberts CW; Nelson PL
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):182-7. PubMed ID: 17444806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of topical diclofenac and prednisolone eyedrops in laser in situ keratomileusis patients.
    Vantesone DL; Luna JD; Muiño JC; Juárez CP
    J Cataract Refract Surg; 1999 Jun; 25(6):836-41. PubMed ID: 10374166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-inflammatory effect of a local combination therapy with diclofenac and prednisolone vs. indomethacin and prednisolone. A laser flare cell photometry study].
    Hessemer V; Schmitt K
    Ophthalmologe; 1994 Apr; 91(2):224-8. PubMed ID: 8012141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical indomethacin solution versus dexamethasone solution for treatment of inflamed pterygium and pinguecula: a prospective randomized clinical study.
    Frucht-Pery J; Siganos CS; Solomon A; Shvartzenberg T; Richard C; Trinquand C
    Am J Ophthalmol; 1999 Feb; 127(2):148-52. PubMed ID: 10030555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prednisolone and dexamethasone are systemically absorbed after topical application of ophthalmic suspensions in healthy dogs.
    Ewald MM; Rankin AJ; Meekins JM; Magnin G; KuKanich B
    Am J Vet Res; 2022 Jan; 83(4):339-348. PubMed ID: 35038305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose uniformity of topical corticosteroid preparations: difluprednate ophthalmic emulsion 0.05% versus branded and generic prednisolone acetate ophthalmic suspension 1%.
    Stringer W; Bryant R
    Clin Ophthalmol; 2010 Oct; 4():1119-24. PubMed ID: 20957058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-inflammatory effects and aqueous humor concentration of various nonsteroidal anti-inflammatory drugs in extracapsular cataract surgery].
    Hessemer V; Schmitt K; Jacobi A
    Klin Monbl Augenheilkd; 1996 Mar; 208(3):161-6. PubMed ID: 8699774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.